Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi Core EURO STOXX 50 UCITS ETF EUR Dist
CD5 · LU1681047319 · class UCITS ETF EUR Dist · EUR · domicile Luxembourg
Equity · Eurozone · Large capSFDR art. 6
Index tracked: EURO STOXX 50 Net Return EUR
- TER
- 0.09%+ trans. 0.05%
- Fund size
- 966 m EUR
- Tracking difference
- +0.58%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 13 Feb 2018 · costs from the KID as of 2 Sept 2026 · 57 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of EURO STOXX 50 Index, and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the index constituents are included in the Index return. EURO STOXX® 50 Index is an equity index representative of the 50 leading…
Performance since series start (in euro) — base 100
14 Feb 2018 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +23.8% |
| 3 years | +64.7% |
| 5 years | +75.7% |
| 10 years | series too young |
| Since series start | +144.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 15.64% | 15.48% | 17.44% |
| Max drawdown | −10.88% | −16.41% | −24.45% |
| Sharpe | 1.07 | 0.76 | 0.45 |
| Sortino | 1.66 | 1.08 | 0.64 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CD5 · LU16810473191
RebalixCD5 · LU1681047319 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +21.80% | +21.20% | +0.60% |
| 2024 | +11.59% | +11.01% | +0.58% |
| 2023 | +22.79% | +22.23% | +0.56% |
| 2022 | −9.04% | −9.49% | +0.45% |
| 2021 | +23.93% | +23.34% | +0.58% |
Distributions · per share, in EUR
Frequency: annual · last 12 months: 2.32 EUR (2.24% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 2.32 | +3.01% |
| 2024 | 1 | 2.18 | +3.07% |
| 2023 | 1 | 2.00 | +3.36% |
| 2022 | 1 | 1.75 | +2.60% |
| 2021 | 1 | 1.24 | +2.24% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 57 securities · top-10 weight = 41.8%
| Top holdings | Weight |
|---|---|
| 8.6% | |
| 4.6% | |
| 4.2% | |
| 4.1% | |
| 4.0% | |
| 3.9% | |
| 3.7% | |
| 3.1% | |
| 2.8% | |
| 2.8% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
V50D · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
CD5 · Euronext Paris
+ 23 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1681047319
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1681047319
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CD5 · LU16810473192